LN-971332
4'-C-Fluoro-uridine , 98% HPLC , 1613589-24-4
Update time: 2023-04-23
PRODUCT Properties
| Density | 1.77±0.1 g/cm3(Predicted) |
| pka | 9.39±0.10(Predicted) |
| form | Solid |
| color | Off-white to yellow |
Description and Uses
EIDD-2749 (4'-Fluorouridine) is an orally active RdRp inhibitor. EIDD-2749 effectively blocks the replication of RSV and SARS-CoV-2. EIDD-2749 also exhibits activity against HCV and lymphocytic choriomeningitis virus (LCMV). EIDD-2749 is a promising oral therapeutic candidate for COVID-19 and is also suitable for research on other RNA viruses[1][2][3].